AWMS
NVCR icon

Advocacy Wealth Management Services’s NovoCure NVCR Stock Holding History

Advocacy Wealth Management Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-800
Closed -$7K – 362
2016
Q3 		$7K Buy
+800
New +$7.3K ﹤0.01% 294
2016
Q2 		– Sell
-800
Closed -$12K – 435
2016
Q1 		$12K Buy
+800
New +$11.5K 0.01% 335

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Advocacy Wealth Management Services's NVCR Position: Q4 2016 in Review

Advocacy Wealth Management Services sold out of NovoCure (NVCR) in Q4 2016, closing a stake of 800 shares — an estimated $7K sold.

Advocacy Wealth Management Services first reported a position in NVCR in Q1 2016 and held it in 2 quarters. The position peaked at $12K in Q1 2016. 78 funds tracked by Wall St. Rank hold NVCR as of Q4 2016.

  • Advocacy Wealth Management Services reported no remaining NovoCure position as of Q4 2016 after selling out during the quarter.
  • Advocacy Wealth Management Services sold 800 NovoCure shares in Q4 2016, an estimated $7K.
  • Advocacy Wealth Management Services first reported a position in NovoCure in Q1 2016 and held it in 2 quarters.
  • Advocacy Wealth Management Services's NovoCure position peaked at $12K in Q1 2016.
  • 78 funds tracked by Wall St. Rank held NovoCure as of Q4 2016.

Based on Advocacy Wealth Management Services's 13F filing for Q4 2016, filed 27 Jan 2017.